Prior to joining Cynvec, Mr. Stonebanks led the global healthcare & life science mergers and acquisitions efforts at IBM, advising the company on its healthcare and life science strategy. He was previously Vice President and General Manager at Johnson & Johnson where he co-founded and ran The Macroflux(R) Corporation, a private drug delivery company spun out from Johnson & Johnson in October 2006 through a $100 million deal funded by a syndicate of venture and private equity investors. Before J&J, Mr. Stonebanks founded and served as executive director and leader of the Oncology Biologics Business Unit at Centocor, a unit in the Global Marketing group that integrated marketing, medical affairs, market research and health outcomes.
Mr. Stonebanks completed his undergraduate degree in Exercise Physiology at the University of Victoria, B.C., Canada and his MBA in Pharmaceutical Marketing at St. Joseph's University in Philadelphia.
About Cynvec LLC
Cynvec was founded in 2004 and is a development stage biotech company
based in New York City. The Company is focused on developing Sindbis-based
viral vectors as standalone oncolytic therapeutics, delivery systems for
monoclonal antibodies and cytokines as well as cancer diagnostic products.
The Sindbis vector system, originally developed at NYU School of Medicine,
represents a unique, patented platform technology for numerous commercial
applications. The company is developing therapi
|SOURCE Cynvec LLC|
Copyright©2008 PR Newswire.
All rights reserved